We used an equimolar mixture of the epitope peptides (Trp2, GP100, and Tyr) to stimulate tumor antigen-specific T cell responses by assessing IFN-γ production in splenocytes following two IT doses of exoSTING or free CDN1. The gene discussed is BAK1; the disease is neoplasm.